Browse 69 Items
17 August 2016  // 

In conversation with Dr. Glen Franklin, Medical Director of Kentucky Organ Donor Affiliates (KODA)

In this interview Dr. Franklin discusses the data from his two publications examining the UNOS database and efficacy of machine perfusion.1,2 Read More ›
17 August 2016  // 

Hypothermic machine perfusion improves Doppler ultrasonography resistive indices and long-term allograft function after renal transplantation: a single-centre analysis

This retrospective study evaluated the impact of hypothermic machine perfusion (HMP) on Doppler ultrasound parameters and graft function in paired kidneys (n=15 pairs), where the kidney maintained with HMP had a longer cold ischemia period. Potential benefits in kidneys obtained from donation after cardiac death (DCD) versus donation after brain death (DBD) subgroups were also investigated. Read More ›
17 August 2016  // 

Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation

Delayed graft function (DGF) is a common complication experienced by kidney transplant recipients and has been associated with poor clinical outcomes, making it a potential risk factor for acute rejection. This observational study aimed to evaluate the association of DGF and biopsy-driven acute rejection (BPAR) in kidney transplant recipients (n=645) in a Canadian transplant center over 12 years. Read More ›
18 January 2016  // 

Abstract #BO139: ESOT 2015 Deciphering the de novo metabolism of kidneys during hypothermic machine perfusion using isotopic NMR tracer studies

J. Nath, et al. University Hospital Birmingham, University of Birmingham, UK De novo metabolic pathways are active during hypothermic machine perfusion (HMP) according to data from a group of researchers at the University of Birmingham, UK. Read more. Read More ›
18 January 2016  // 

Abstract #O258: ESOT 2015 End-ischemic hypothermic in-house machine perfusion improves 1-year graft survival in expanded criteria donor kidneys

A. Gallinat, et al. Universitätsklinikum Essen, Universitätsklinikum Bonn, Germany The use of hypothermic machine perfusion (HMP) after initial storage on ice (end-ischemic HMP) reduces the rate of delayed graft function (DGF) and improves 1-year graft survival of kidneys compared with static cold storage (SCS) according to a study by researchers in Germany…(Read more). Read More ›
18 January 2016  // 

Abstract #P702: ESOT 2015 Hypothermic machine perfusion of kidneys from living donors

J. Malaise, et al. Universite de Montréal, Québec, Canada While HMP has been widely studied in deceased donor kidneys, a group from Université de Montréal, Canada, investigated hypothermic machine perfusion (HMP) as a means for reducing the occurrence of potential adverse effects during travel in paired kidney exchange programs. Read More ›